BioCentury | Mar 18, 2021
Management Tracks

Clyburn takes helm as president of Merck’s human health franchise; plus Iovance, Harmony, Shattuck and more

...Kapadia as CFO, effective March 29. Most recently, Kapadia served as CFO of NASH play Intercept Pharmaceuticals Inc....
BioCentury | Mar 17, 2021
Management Tracks

High-profile departures at Sage, bluebird as Cloonan, Davidson depart; plus CBC Group, Turning Point, Agilent, Intercept, Centessa, Beam and more

...China, head of value evidence and outcomes and CMO. Sandip Kapadia is stepping down as CFO of Intercept Pharmaceuticals Inc. (NASDAQ:ICPT...
...general counsel at Sarepta Therapeutics Inc. (NASDAQ:SRPT). Gunjan Ohri Agilent Technologies Inc. Turning Point Therapeutics Inc. Moderna Inc. CareDx Inc. CBC Group Intercept Pharmaceuticals Inc. Sagimet...
BioCentury | Mar 10, 2021
Management Tracks

Ex-BARDA Director Bright joins Rockefeller Foundation; plus Lilly, Q32 Bio, Apollomics, Axial and Grip

...inflammatory and autoimmune play Q32 Bio Inc. as CMO after spending nearly five years at NASH company Intercept Pharmaceuticals Inc....
BioCentury | Mar 3, 2021
Product Development

eGenesis $125M C round to support clinical trials of kidney, islet transplants from engineered pigs

...conjunction with the series C, Polaris’ Isaac Ciechanover and Mark Pruzanski, founder and former CEO of Intercept Pharmaceuticals Inc....
BioCentury | Feb 23, 2021
Management Tracks

Kite’s Takeshita to head R&D for Daiichi Sankyo; plus TScan adds CFO Silver, Hahn joins Blackfynn’s board and moves at Intercept, Kira, Insilico, BioXcel and Re-Vana

...an undisclosed partner to acquire rights to a Phase III-ready Parkinson’s drug and added Karl Kieburtz as CMO.Intercept Pharmaceuticals Inc....
BioCentury | Feb 3, 2021
Management Tracks

Lilly Asia’s Li joins AffaMed as president; plus moves at Actimed, Elicio, Life Biosciences, OncoNano, Tollys, HighTide and Patient Square Capital

...Leigh MacConell as chief development officer. She was most recently SVP of clinical development at Intercept Pharmaceuticals Inc....
BioCentury | Dec 11, 2020
Management Tracks

Founding Intercept CEO Pruzanski prepares to hand over the reins

...will ring in the New Year with a new face in the corner office.After guiding Intercept Pharmaceuticals Inc....
...he was SVP and COO of Sanofi’s U.S. pharmaceuticals unit.TARGETSFXR (NR1H4) - Farnesoid X receptor Jeff Cranmer Intercept Pharmaceuticals Inc. Mark...
BioCentury | Nov 7, 2020
Management Tracks

Shah retiring from Lilly; plus moves at Trillium, Codagenix, VectivBio, Deep Genomics, Novo Ventures and Theratechnologies

...global head of licensing at Lonza Group Ltd. (SIX:LONN); and Venugopal was an executive director at Intercept Pharmaceuticals Inc....
BioCentury | Sep 30, 2020
Distillery Therapeutics

Endogenous bile acid identified for obesity and diabetes

...with diet-induced obesity, cholic acid-7-sulfate reduced blood glucose levels, increased insulin levels and improved glucose tolerance.Intercept Pharmaceuticals Inc....
BioCentury | Sep 5, 2020
Product Development

Sept. 4 Quick Takes: HiFiBiO in second cancer deal with Gilead; plus Bridgewest-Pfizer, Amarin, Intercept, Santhera-Idorsia, CMS, Ascendis

...is down $0.74 (15%) to $4.30 from its Wednesday close (see “Amarin Set to Appeal”).Intercept cutting staff Intercept Pharmaceuticals Inc....
...DSP-1747, 6ecdca, int-747, oca) Vamorolone (VBP15) Gilead Sciences Inc. Kite Pharma Inc. Amarin Corp. plc Dr. Reddy's Laboratories Ltd. Hikma Pharmaceuticals plc Intercept Pharmaceuticals Inc. Santhera...
Items per page:
1 - 10 of 262
BioCentury | Mar 18, 2021
Management Tracks

Clyburn takes helm as president of Merck’s human health franchise; plus Iovance, Harmony, Shattuck and more

...Kapadia as CFO, effective March 29. Most recently, Kapadia served as CFO of NASH play Intercept Pharmaceuticals Inc....
BioCentury | Mar 17, 2021
Management Tracks

High-profile departures at Sage, bluebird as Cloonan, Davidson depart; plus CBC Group, Turning Point, Agilent, Intercept, Centessa, Beam and more

...China, head of value evidence and outcomes and CMO. Sandip Kapadia is stepping down as CFO of Intercept Pharmaceuticals Inc. (NASDAQ:ICPT...
...general counsel at Sarepta Therapeutics Inc. (NASDAQ:SRPT). Gunjan Ohri Agilent Technologies Inc. Turning Point Therapeutics Inc. Moderna Inc. CareDx Inc. CBC Group Intercept Pharmaceuticals Inc. Sagimet...
BioCentury | Mar 10, 2021
Management Tracks

Ex-BARDA Director Bright joins Rockefeller Foundation; plus Lilly, Q32 Bio, Apollomics, Axial and Grip

...inflammatory and autoimmune play Q32 Bio Inc. as CMO after spending nearly five years at NASH company Intercept Pharmaceuticals Inc....
BioCentury | Mar 3, 2021
Product Development

eGenesis $125M C round to support clinical trials of kidney, islet transplants from engineered pigs

...conjunction with the series C, Polaris’ Isaac Ciechanover and Mark Pruzanski, founder and former CEO of Intercept Pharmaceuticals Inc....
BioCentury | Feb 23, 2021
Management Tracks

Kite’s Takeshita to head R&D for Daiichi Sankyo; plus TScan adds CFO Silver, Hahn joins Blackfynn’s board and moves at Intercept, Kira, Insilico, BioXcel and Re-Vana

...an undisclosed partner to acquire rights to a Phase III-ready Parkinson’s drug and added Karl Kieburtz as CMO.Intercept Pharmaceuticals Inc....
BioCentury | Feb 3, 2021
Management Tracks

Lilly Asia’s Li joins AffaMed as president; plus moves at Actimed, Elicio, Life Biosciences, OncoNano, Tollys, HighTide and Patient Square Capital

...Leigh MacConell as chief development officer. She was most recently SVP of clinical development at Intercept Pharmaceuticals Inc....
BioCentury | Dec 11, 2020
Management Tracks

Founding Intercept CEO Pruzanski prepares to hand over the reins

...will ring in the New Year with a new face in the corner office.After guiding Intercept Pharmaceuticals Inc....
...he was SVP and COO of Sanofi’s U.S. pharmaceuticals unit.TARGETSFXR (NR1H4) - Farnesoid X receptor Jeff Cranmer Intercept Pharmaceuticals Inc. Mark...
BioCentury | Nov 7, 2020
Management Tracks

Shah retiring from Lilly; plus moves at Trillium, Codagenix, VectivBio, Deep Genomics, Novo Ventures and Theratechnologies

...global head of licensing at Lonza Group Ltd. (SIX:LONN); and Venugopal was an executive director at Intercept Pharmaceuticals Inc....
BioCentury | Sep 30, 2020
Distillery Therapeutics

Endogenous bile acid identified for obesity and diabetes

...with diet-induced obesity, cholic acid-7-sulfate reduced blood glucose levels, increased insulin levels and improved glucose tolerance.Intercept Pharmaceuticals Inc....
BioCentury | Sep 5, 2020
Product Development

Sept. 4 Quick Takes: HiFiBiO in second cancer deal with Gilead; plus Bridgewest-Pfizer, Amarin, Intercept, Santhera-Idorsia, CMS, Ascendis

...is down $0.74 (15%) to $4.30 from its Wednesday close (see “Amarin Set to Appeal”).Intercept cutting staff Intercept Pharmaceuticals Inc....
...DSP-1747, 6ecdca, int-747, oca) Vamorolone (VBP15) Gilead Sciences Inc. Kite Pharma Inc. Amarin Corp. plc Dr. Reddy's Laboratories Ltd. Hikma Pharmaceuticals plc Intercept Pharmaceuticals Inc. Santhera...
Items per page:
1 - 10 of 262